KHN executive editor Damon Darlin wades through mounds of health care policy stories — so you don’t have to.
Some large employers interpreted themselves as exempt from new federal laws that say tests for the coronavirus should be free to patients. Large academic medical centers are holding back from sending bills to these patients to avoid a backlash over surprise billing.
As an electron microscopist at the National Institutes of Health’s Rocky Mountain Laboratories in Montana, Elizabeth Fischer has captured stunning images of emerging pathogens such as Ebola, the MERS coronavirus and now SARS-CoV-2.
Maine investigators find one patient’s saga with O’NA HealthCare offers a cautionary tale for anyone looking for cut-rate coverage online.
Accident deaths are typically the biggest source of donor organs nationwide. But when the coronavirus forced Californians indoors, accidents declined.
Children’s hospitals were generally in good shape before COVID-19, but now their revenues are plunging as beds they reserved to assist in the pandemic effort remain empty.
Early in the outbreak, some coroners and medical examiners didn’t have enough tests to use for people who died unexpectedly at home to see whether the coronavirus was a factor. Now, as testing gradually becomes widely available, more such mysteries could be solved.
A podcast listener who works in the health insurance industry says that when you’re trying to untangle a problem with your health insurance company ask the representative on the phone to slow down. And if need be, don’t hesitate to ask to speak with a supervisor.
Under pressure from organizations representing doctors, nurses, hospitals and other care providers, a handful of states are offering them protections from civil lawsuits over medical treatment.
Thousands of researchers worldwide are looking for a treatment that will go beyond what remdesivir can do for COVID patients.